CDK5 inhibitor 20-223
≥99%
- Product Code: 108101
CAS:
865317-30-2
| Molecular Weight: | 305.37 g./mol | Molecular Formula: | C₁₉H₁₉N₃O |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C, sealed, dry |
Product Description:
CDK5 inhibitor 20-223 is primarily used in research settings to study the role of cyclin-dependent kinase 5 (CDK5) in various cellular processes. It is particularly valuable in neuroscience, where it helps investigate CDK5's involvement in neurodegenerative diseases such as Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis (ALS). By inhibiting CDK5 activity, researchers can better understand its impact on neuronal function, synaptic plasticity, and cell death pathways. Additionally, this inhibitor is utilized in cancer research to explore CDK5's role in tumor progression and metastasis, as aberrant CDK5 activity has been linked to certain cancers. Its application extends to drug discovery, where it serves as a tool for developing targeted therapies for diseases associated with CDK5 dysregulation.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | ฿18,000.00 |
+
-
|
| 0.010 | 10-20 days | ฿31,500.00 |
+
-
|
| 0.025 | 10-20 days | ฿58,500.00 |
+
-
|
CDK5 inhibitor 20-223
CDK5 inhibitor 20-223 is primarily used in research settings to study the role of cyclin-dependent kinase 5 (CDK5) in various cellular processes. It is particularly valuable in neuroscience, where it helps investigate CDK5's involvement in neurodegenerative diseases such as Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis (ALS). By inhibiting CDK5 activity, researchers can better understand its impact on neuronal function, synaptic plasticity, and cell death pathways. Additionally, this inhibitor is utilized in cancer research to explore CDK5's role in tumor progression and metastasis, as aberrant CDK5 activity has been linked to certain cancers. Its application extends to drug discovery, where it serves as a tool for developing targeted therapies for diseases associated with CDK5 dysregulation.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :